QT
DFTX

Quantbot Technologies’s Definium Therapeutics DFTX Stock Holding History

Quantbot Technologies’s Portfolio DFTX Stock Details DFTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-1,649
Closed -$22.1K – 1992
2025
Q4 		$22.1K Buy
+1,649
New +$20.4K ﹤0.01% 1563
2024
Q3 		– Sell
-1,577
Closed -$11.4K – 1693
2024
Q2 		$11.4K Buy
+1,577
New +$13.8K ﹤0.01% 1348

Other funds holding DFTX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Quantbot Technologies's DFTX Position: Q1 2026 in Review

Quantbot Technologies sold out of Definium Therapeutics (DFTX) in Q1 2026, closing a stake of 1,649 shares — an estimated $22.1K sold.

Quantbot Technologies first reported a position in DFTX in Q2 2024 and held it in 2 quarters. The position peaked at $22.1K in Q4 2025. 247 funds tracked by Wall St. Rank hold DFTX as of Q1 2026.

  • Quantbot Technologies reported no remaining Definium Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Quantbot Technologies sold 1,649 Definium Therapeutics shares in Q1 2026, an estimated $22.1K.
  • Quantbot Technologies first reported a position in Definium Therapeutics in Q2 2024 and held it in 2 quarters.
  • Quantbot Technologies's Definium Therapeutics position peaked at $22.1K in Q4 2025.
  • 247 funds tracked by Wall St. Rank held Definium Therapeutics as of Q1 2026.

Based on Quantbot Technologies's 13F filing for Q1 2026, filed 13 May 2026.